To: tuck who wrote (2560) | 7/24/2006 3:16:20 PM | From: Ian@SI | | | PRAN up 60% on re-release of last week's PR on PBT2 - pre clinical Alzheimer's research. Was up about 80% earlier today. |
| biotech fireworks | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
To: tuck who wrote (2560) | 7/25/2006 9:51:16 AM | From: Saulamanca | | | MNTA up another 30%
MNTA Momenta Pharma and Sandoz sign exclusive collaboration to develop complex generics and follow-on versions of biotechnology drugs
Co announces an exclusive collaboration with Sandoz, the generics business of Novartis (NVS), to develop four follow-on and complex generic versions of previously approved recombinant biotechnology and complex drugs. As part of the collaboration, Sandoz will make an initial payment of $75 mln to the co for the purchase of approx 4.7 mln shares at a price of $15.93 per share, a 30% premium to the trailing 30-day average. The co is also eligible to receive up to $188 mln in additional payments if all milestones are achieved for the four product candidates. The collaboration will include one late-stage compound from the co's pipeline and two late-stage compounds from Sandoz. |
| biotech fireworks | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
To: Saulamanca who wrote (2564) | 7/25/2006 10:04:58 AM | From: tuck | | | And may we say it's about time! They've been promising a deal for a good while now. Since my MNTA position is much larger than my ENCY position, it sure takes the sting out of the latter's setback.
Cheers, Tuck |
| biotech fireworks | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (2) |
|
To: tuck who wrote (2565) | 7/25/2006 10:11:48 AM | From: Robohogs | | | Same here! Came into today grimacing and now I feel much better. Nice seeing the short covering in some other bios (un-named here as only up 5-10%).
Not sure what impact is on charity portfolio as both are there.
Jon |
| biotech fireworks | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |